ANX
Adventrx Pharmaceuticals
Biopharmaceutical company developing drugs for the treatment of vascular, infectious and oncologic diseases
CUSIP: 00764X202HealthcareUS1 holder
Adventrx Pharmaceuticals
Biopharmaceutical company developing drugs for the treatment of vascular, infectious and oncologic diseases
No insider transactions reported in the last 6 months. Look across all recorded history →